Compare ALKS & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | HBM |
|---|---|---|
| Founded | 1987 | 1927 |
| Country | Ireland | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 10.4B |
| IPO Year | 2012 | 2005 |
| Metric | ALKS | HBM |
|---|---|---|
| Price | $50.21 | $22.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 3 |
| Target Price | ★ $43.43 | $25.00 |
| AVG Volume (30 Days) | 1.7M | ★ 4.3M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 0.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,475,899,000.00 | N/A |
| Revenue This Year | $24.26 | $30.66 |
| Revenue Next Year | $4.47 | $14.54 |
| P/E Ratio | ★ N/A | $21.47 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.17 | $9.02 |
| 52 Week High | $55.67 | $32.15 |
| Indicator | ALKS | HBM |
|---|---|---|
| Relative Strength Index (RSI) | 40.52 | 45.44 |
| Support Level | $27.78 | $19.74 |
| Resistance Level | $55.67 | $23.73 |
| Average True Range (ATR) | 1.79 | 1.05 |
| MACD | -0.79 | 0.20 |
| Stochastic Oscillator | 10.94 | 55.60 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Hudbay Minerals Inc is a copper-focused critical minerals company with three long-life operations and a pipeline of copper growth projects in Canada, Peru, and the United States. Its operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada), and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the company, which is complemented by gold, zinc, silver, and molybdenum production. Hudbay's growth pipeline includes the Copper World project and the Mason project in the USA, and the Llaguen project in Peru. The company's reportable segments are: Peru, which generates the maximum revenue, Manitoba, British Columbia, and Arizona. Geographically, it generates maximum revenue from China and Canada.